Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Response of Established Human Breast Tumors to Vaccination with Mammaglobin-A cDNA

14 Sept 2004

Abstract excerpt

BACKGROUND: A novel breast cancer-associated antigen, mammaglobin-A, is expressed in 80% of primary breast tumors. The characterization of immune responses against this highly expressed breast cancer-specific antigen would be of value in the development of new therapeutic strategies for breast cancer. METHODS: We developed an in vivo model using human leukocyte antigen-A*0201/human CD8+ (HLA-A2+/hCD8+)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Glycosylation and Glycoproteins Research
Share to Immunotherapy and Immune Responses

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15367572
DOI: 10.1093/jnci/djh261

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Response of Established Human Breast Tumors to Vaccination with Mammaglobin-A cDNAPMID 15367572Read ↗

CD8 T-cell responses against cyclin B1 in breast cancer patients with tumors overexpressing p53.Semantic proximity Read ↗

The role of tumor-associated antigens in the biology and immunotherapy of breast cancer.Semantic proximity Read ↗

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide.Semantic proximity Read ↗

MAM domain containing 2 is a potential breast cancer biomarker that exhibits tumour‐suppressive activitySemantic proximity Read ↗

Development of Natural Protein Microarrays for Diagnosing Cancer Based on an Antibody Response to Tumor AntigensSemantic proximity Read ↗

Identification of tumor‐associated antigens by screening phage‐displayed human cDNA libraries with sera from tumor patientsSemantic proximity Read ↗

Protection against mammary tumor growth by vaccination with full-length, modified humanErbB-2 DNASemantic proximity Read ↗

Identification of HLA-A*0201-restricted T cell epitopes derived from the novel overexpressed tumor antigen calcium-activated chloride channel 2.Semantic proximity Read ↗

Identification of a panel of tumor-associated antigens from breast carcinoma cell lines, solid tumors and testis cDNA libraries displayed on lambda phageSemantic proximity Read ↗

Production and characterization of monoclonal antibodies against major histocompatibility complex class I chain-related gene A.Semantic proximity Read ↗

Cell surface profiling with peptide libraries yields ligand arrays that classify breast tumor subtypesSemantic proximity Read ↗

Effects of HLA status and HER2 status on outcomes in breast cancer patients at risk for recurrence - Implications for vaccine trial design.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.